Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular and Clinical Features of Non-Burkitt’s, Diffuse Large-Cell Lymphoma of B-Cell Type Associated With the c-MYC/Immunoglobulin Heavy-Chain Fusion Gene

1 Feb 2000

Abstract excerpt

PURPOSE: t(8;14)(q24;q32) and/or c-MYC/immunoglobulin heavy-chain (IGH) fusion gene have been observed not only in Burkitt's lymphoma (BL) but also in a proportion of non-BL, diffuse large-cell lymphoma of B-cell type (DLCL). We explored molecular features of DLCL with c-MYC/IGH fusion and the impact of this genetic abnormality on clinical outcome of DLCL. PATIENTS AND METHODS: A total of 203 cases of non-BL DLCL...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Lymphocytic Leukemia Research
Share to Lymphoma Diagnosis and Treatment
Share to Multiple Myeloma Research and Treatments

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 10653866
DOI: 10.1200/jco.2000.18.3.510

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular and Clinical Features of Non-Burkitt’s, Diffuse Large-Cell Lymphoma of B-Cell Type Associated With the c-MYC/Immunoglobulin Heavy-Chain Fusion GenePMID 10653866Read ↗

Diffuse large B-cell lymphomas of immunoblastic type are a major reservoir for MYC-IGH translocations.Semantic proximity Read ↗

Genetic features of precursor B-cell phenotype Burkitt leukemia with IGH-MYC rearrangement.Semantic proximity Read ↗

IG-MYC+ neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomasSemantic proximity Read ↗

Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype.Semantic proximity Read ↗

<i>MYC</i> translocation and an increased copy number predict poor prognosis in adult diffuse large B‐cell lymphoma (DLBCL), especially in germinal centre‐like B cell (GCB) typeSemantic proximity Read ↗

Double‐hit <scp>BCL</scp>2/<scp>MYC</scp> translocations in a consecutive cohort of patients with large B‐cell lymphoma – a single centre's experienceSemantic proximity Read ↗

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survivalSemantic proximity Read ↗

BCL2 and MYC Dual-Hit Lymphoma/LeukemiaSemantic proximity Read ↗

B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.Semantic proximity Read ↗

High-resolution architecture and partner genes of MYC rearrangements in lymphoma with DLBCL morphologySemantic proximity Read ↗

<scp>MYC</scp> translocation partner gene determines survival of patients with large B‐cell lymphoma with <scp>MYC</scp>‐ or double‐hit <scp>MYC</scp>/<scp>BCL</scp>2 translocationsSemantic proximity Read ↗

Similar patterns of genomic alterations characterize primary mediastinal large-B-cell lymphoma and diffuse large-B-cell lymphoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.